secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001641172-25-016293
Event type: regulatory
Sentiment:  positive
Materiality: 0.90
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD receives FDA PMA approval for CGuard Prime carotid stent system; triggers $17.9M warrant tranche
--------------------------------------------------------------------------------

- FDA approved CGuard Prime carotid stent system on June 23, 2025 for stroke prevention in carotid artery stenosis.
- Pivotal C-GUARDIANS trial (316 patients) showed lowest 30-day (0.95%) and 1-year (1.93%) major adverse event rates.
- FDA approval triggers second warrant tranche; gross proceeds expected $17.9M if exercised in full.
- Proceeds to fund U.S. commercial launch, new regulatory pathways, and product development.
- Over 65,000 CGuard Prime implants to date; investors include Marshall Wace, OrbiMed, etc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225016293/0001641172-25-016293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225016293/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer